AAAAAA
Results:
1-15
|
Results: 15
Authors:
Sherif, A
De la Torre, M
Malmstrom, PU
Thorn, M
Citation: A. Sherif et al., Lymphatic mapping and detection of sentinel nodes in patients with bladdercancer, J UROL, 166(3), 2001, pp. 812-815
Authors:
Loskog, A
Bjorkland, A
Brown, MP
Korsgren, O
Malmstrom, PU
Totterman, TH
Citation: A. Loskog et al., Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer, J UROL, 166(3), 2001, pp. 1093-1097
Authors:
Bird, VG
Soloway, MS
Malmstrom, PU
Citation: Vg. Bird et al., Intravesical chemotherapy in the treatment of superficial bladder cancer, CURR CLIN U, 2001, pp. 183-223
Authors:
Wester, K
Wahlund, E
Sundstrom, C
Ranefall, P
Bengtsson, E
Russell, PJ
Ow, KT
Malmstrom, PU
Busch, C
Citation: K. Wester et al., Paraffin section storage and immunohistochemistry - Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen, APPL IMMUNO, 8(1), 2000, pp. 61-70
Authors:
Sjostrom, A
Bue, P
Malmstrom, PU
Carlsson, J
Citation: A. Sjostrom et al., Binding of I-125 after administration of I-125-EGF-dextran, I-125-EGF or I-125 to human bladder cancer spheroids, INT J ONCOL, 17(3), 2000, pp. 559-564
Authors:
Bue, P
Holmberg, AR
Marquez, M
Westlin, JE
Nilsson, S
Malmstrom, PU
Citation: P. Bue et al., Intravesical administration of EGF-dextran conjugates in patients with superficial bladder cancer, EUR UROL, 38(5), 2000, pp. 584-589
Improved patient outcomes with BCG immunotherapy vs. chemotherapy - Swedish and worldwide experience
Authors:
Malmstrom, PU
Citation: Pu. Malmstrom, Improved patient outcomes with BCG immunotherapy vs. chemotherapy - Swedish and worldwide experience, EUR UROL, 37, 2000, pp. 16-20
Authors:
Droller, MJ
Malmstrom, PU
Citation: Mj. Droller et Pu. Malmstrom, Premalignant lesions and carcinoma in situ in bladder neoplasia - Introduction and overview, SC J UROL N, 34, 2000, pp. 62-66
Authors:
Wester, K
Andersson, AC
Ranefall, F
Bengtsson, E
Malmstrom, PU
Busch, C
Citation: K. Wester et al., Cultured human fibroblasts in agarose gel as a multi-functional control for immunohistochemistry. Standardization of Ki67 (MIBI) assessment in routinely processed urinary bladder carcinoma tissue, J PATHOLOGY, 190(4), 2000, pp. 503-511
Authors:
Carlsson, J
Blomquist, E
Gedda, L
Liljegren, A
Malmstrom, PU
Sjostrom, A
Sundin, A
Westlin, JE
Zhao, QH
Tolmachev, V
Lundqvist, H
Citation: J. Carlsson et al., Conjugate chemistry and cellular processing of EGF-Dextran, ACTA ONCOL, 38(3), 1999, pp. 313-321
Authors:
Mahdy, E
Yoshihiro, S
Zech, L
Wester, K
Pan, Y
Busch, C
Dohner, H
Kallioniemi, O
Bergerheim, U
Malmstrom, PU
Citation: E. Mahdy et al., Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer, ANTICANC R, 19(1A), 1999, pp. 7-12
Authors:
Nygren, P
Csoka, K
Larsson, R
Busch, C
Wester, K
Malmstrom, PU
Citation: P. Nygren et al., Activity of standard and investigational cytotoxic drugs in primary cultures of tumor cells from patients with kidney and urinary bladder carcinomas, J UROL, 162(6), 1999, pp. 2200-2204
Authors:
Malmstrom, PU
Wijkstrom, H
Lundholm, C
Wester, K
Busch, C
Norlen, BJ
Citation: Pu. Malmstrom et al., 5-year followup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma, J UROL, 161(4), 1999, pp. 1124-1127
Authors:
Wester, K
Ranefall, P
Bengtsson, E
Busch, C
Malmstrom, PU
Citation: K. Wester et al., Automatic quantification of microvessel density in urinary bladder carcinoma, BR J CANC, 81(8), 1999, pp. 1363-1370
Authors:
Ranefall, P
Wester, K
Busch, C
Malmstrom, PU
Bengtsson, E
Citation: P. Ranefall et al., Automatic quantification of microvessels using unsupervised image analysis, ANAL CELL P, 17(2), 1998, pp. 83-92
Risultati:
1-15
|